Abstract

Dr. Sara Daoudi*, Imane Adrif, Sihame Lkhoyaali, Ibrahim El Ghissassi, Hind Mrabti and Hassan Errihani

ABSTRACT

Background: Contraception is very challenging for reproductive-aged breast cancer patients, due to limitation in nonhormonal options. Contraceptive methods used by this population are very heterogeneous and may be insufficient, resulting in an increased risk for unwanted pregnancy. Methods: This is a survey conducted in reproductive-aged breast cancer patients at the Department of Medical Oncology at the National Institute of Oncology of Rabat - Morocco. It is an analytical study of contraceptive methods used before diagnosis, during and after cancer treatment, what identifies the level of contraceptive counseling. Results: 104 young patients with breast cancer respond to the survey. The mean age was 39 years. 78% of the cases had a localized disease and 22% were metastatic. 87% had received treatment and 13% were under surveillance. Sexual activity was maintained in 62% of the cases. 91% used contraception before the diagnosis of breast cancer. After the diagnosis was announced, 67% used contraception. 74% of patients were informed that hormonal contraception is not recommended. This information was received from medical staff in 89% of cases. 48% were informed when the diagnosis was announced, 29% before the start of chemotherapy, 15% during chemotherapy and 8% at the end of treatment. Conclusion: Reproductive-aged patients require contraceptive counseling after newly diagnosed breast cancer. Contraceptive counseling should be tailored to the needs, concerns, and history of cancer for each patient. Given the lack of information regarding contraception for these patients, oncologists in collaboration with gynecologists should ensure proper contraceptive counseling for better quality of care.